Previous 10 | Next 10 |
TEL AVIV, Israel and ST. LOUIS, Missouri , July 8, 2019 /PRNewswire/ -- As the two organizations move closer to the commencement of the clinical trial to determine the safety and tolerability of the Apograft technology for bone marrow transplantations, Cellect Biotechnology Lt...
Cellect Biotechnology (NASDAQ: APOP ): Q1 GAAP EPADS of -$0.16. Cash and cash equivalents of $9.59M Press Release More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, ,
TEL AVIV, Israel , May 21, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the first quarter ended March 31, 2019 and provided a ...
Tel Aviv, Israel, May 16, 2019 (GLOBE NEWSWIRE) -- Following a review of its business, including the status of its clinical and development programs, resources and capabilities, Cellect Biotechnology Ltd. (Nasdaq: APOP) plans to explore strategic alternatives focused on maximizing sharehold...
Tel Aviv, Israel, May 16, 2019 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced today it has received notification from The Nasdaq Stock Market, LLC that it is not in compliance with the minimum bid price requir...
Thinly traded nano cap Cellect Biotechnology (NASDAQ: APOP ) is up 17% premarket on modestly higher volume in reaction to positive preliminary results from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transpl...
TEL AVIV, Israel , March 27, 2019 /PRNewswire/ -- Further validating its ApoGraft™ technology, Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced positive mid-study data from the Company's Phase I/II study of its A...
TEL AVIV, Israel , March 18, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, today announced operating and financial results for the fourth quarter and full year ended December 31, 2018 , as well as recent corporate ...
Zafgen (NASDAQ: ZFGN ) -26% on suspension of IND for ZGN-1258. More news on: Zafgen, Inc., Pyxis Tankers Inc., ADT Inc., Stocks on the move, Read more ...
NEW YORK, NY / ACCESSWIRE / March 12, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Cellect Biotechnology Ltd. (NASDAQ: APOP) is a biotechnology company, foc...
News, Short Squeeze, Breakout and More Instantly...
Cellect Biotechnology Ltd. Company Name:
APOP Stock Symbol:
NASDAQ Market:
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the...
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning. The stock has now ...